A number for the lupus pre-pregnancy clinic

Design

systematic review and random-effects meta-analysis of 53 observational studies, with meta-regression and prespecified subgroups

Population

33,694 pregnancies in women with systemic lupus erythematosus, databases searched to January 2026

Primary outcome

structural cardiovascular malformations and congenital heart block in offspring

Effect

structural malformations 3.29% (95% CI 2.48–4.21) and heart block 1.29% (0.82–1.88); vs healthy controls OR 3.52 (2.13–5.81), and 1.70 (1.22–2.36) across five adjusted studies

Women with systemic lupus erythematosus (SLE) are told their pregnancies carry cardiac risk for the baby, but the two risks usually get discussed as one thing. A meta-analysis of 53 studies covering 33,694 lupus-associated pregnancies separates them.

Structural cardiovascular malformations occurred in 3.29% of offspring and congenital heart block in 1.29%. Against healthy controls the crude odds ratio for structural malformation was 3.52, falling to 1.70 in a pooled analysis of the five studies that adjusted for confounders. Congenital heart block clustered where it would be expected: studies in which cases arose in anti-SSA/Ro-positive mothers reported a prevalence of 2.64% against 0.63% in studies that did not record antibody status. Study-level meta-regression linked active disease to structural malformations.

What this gives a clinic is an absolute number to say out loud. Three in a hundred is a figure a woman can weigh against the alternative of not conceiving, and it is considerably less alarming than an odds ratio of 3.5 sounds. It also sharpens who needs fetal echocardiography most: antibody-positive women, and women whose disease is not quiet at conception.

• Document anti-SSA/Ro and anti-SSB/La status before conception, not at booking.
• Quote absolute risk — about 3% for a structural cardiac malformation — rather than the odds ratio.
• Aim for quiescent disease before conception; activity tracked with structural malformation in this analysis.
• Arrange fetal echocardiography, and schedule it earlier where anti-SSA/Ro is positive.
• Review disease-modifying medication for pregnancy compatibility at the same visit rather than after a positive test.

Why it matters

It replaces a vague warning about lupus pregnancy with two separate risks and one absolute number.

Don't overread it

These are pooled observational data, and confounder adjustment was incomplete — how much of the risk is lupus itself rather than antibody status, disease activity, drug exposure or simply closer surveillance is still unknown.

The statistics, in plain English

The gap between the crude odds ratio of 3.52 (95% CI 2.13–5.81) and the adjusted 1.70 (95% CI 1.22–2.36) is the important part: roughly half the apparent excess disappeared once the five studies that adjusted for confounders were pooled, and the authors say that adjustment was still incomplete. Both intervals exclude 1.0, so an association remains, but the size of it is unsettled. For congenital heart block the comparative estimate was too imprecise to use at all, because the event is rare and the studies are small.

Read the rest in the app

You have read your two free briefings this month. The app carries all 27 specialties, every morning, free — and this finding is waiting in it.

Get Daily Doctor — free

Scan to keep reading on your phone. No account needed to start.